Business Description
Biofrontera Inc
NAICS : 325411
SIC : 2834
ISIN : US09077D2099
Description
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.05 | |||||
Equity-to-Asset | -0.22 | |||||
Debt-to-Equity | -0.68 | |||||
Debt-to-EBITDA | -0.18 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -7.36 | |||||
Beneish M-Score | -2.65 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -12.1 | |||||
3-Year EBITDA Growth Rate | 2.5 | |||||
3-Year EPS without NRI Growth Rate | 5.7 | |||||
3-Year FCF Growth Rate | 8.9 | |||||
3-Year Book Growth Rate | -32 | |||||
Future 3-5Y Total Revenue Growth Rate | 25.99 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 29.29 | |||||
9-Day RSI | 31.91 | |||||
14-Day RSI | 35.98 | |||||
6-1 Month Momentum % | -51.88 | |||||
12-1 Month Momentum % | -82.98 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.44 | |||||
Quick Ratio | 0.94 | |||||
Cash Ratio | 0.27 | |||||
Days Inventory | 238.15 | |||||
Days Sales Outstanding | 41.24 | |||||
Days Payable | 109.65 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -37.8 | |||||
Shareholder Yield % | -44.47 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 48.99 | |||||
Operating Margin % | -67.18 | |||||
Net Margin % | -69.44 | |||||
FCF Margin % | -73.94 | |||||
ROE % | -474.34 | |||||
ROA % | -69.77 | |||||
ROIC % | -139.69 | |||||
ROC (Joel Greenblatt) % | -513.55 | |||||
ROCE % | -180.98 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.06 | |||||
EV-to-EBIT | -0.23 | |||||
EV-to-EBITDA | -0.24 | |||||
EV-to-Revenue | 0.15 | |||||
EV-to-Forward-Revenue | 0.12 | |||||
EV-to-FCF | -0.2 | |||||
Earnings Yield (Greenblatt) % | -434.78 | |||||
FCF Yield % | -487.95 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BFRI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biofrontera Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 33.252 | ||
EPS (TTM) ($) | -10.2 | ||
Beta | 0 | ||
Volatility % | 133.74 | ||
14-Day RSI | 35.98 | ||
14-Day ATR ($) | 0.13248 | ||
20-Day SMA ($) | 1.090995 | ||
12-1 Month Momentum % | -82.98 | ||
52-Week Range ($) | 0.61 - 13.42 | ||
Shares Outstanding (Mil) | 5.09 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Biofrontera Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Biofrontera Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Biofrontera Inc Frequently Asked Questions
What is Biofrontera Inc(BFRI)'s stock price today?
The current price of BFRI is $0.99. The 52 week high of BFRI is $13.42 and 52 week low is $0.61.
When is next earnings date of Biofrontera Inc(BFRI)?
The next earnings date of Biofrontera Inc(BFRI) is 2024-08-11 Est..
Does Biofrontera Inc(BFRI) pay dividends? If so, how much?
Biofrontera Inc(BFRI) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |